The prevalence of EA/D IgA antibodies was also found to be significantly higher in patients with abnormal liver function (elevated serum liver enzymes) than that in total of ≤30 year old non-NPC patients (χ2 = 8.74, P = 0.003). The gene discussed is CD79A; the disease is nasopharyngeal carcinoma.